The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis

類似資料

• Modularized Perturbation of Alternative Splicing Across Human Cancers
  著者:: Yabing Du, 等
  出版事項: (2019-04-01)
• Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
  著者:: Song, Mengjia, 等
  出版事項: (2018)
• Safety and Efficacy in Relapsed or Refractory Classic Hodgkin's Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical Trials
  著者:: Zhang, Xueyan, 等
  出版事項: (2019)
• Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study
  著者:: Lihua Wang, 等
  出版事項: (2022-01-01)
• The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
  著者:: Sui, Xinbing, 等
  出版事項: (2015)